Bone News and Research RSS Feed - Bone News and Research

Cycle Pharmaceuticals receives license for IP on PARP inhibitor drugs for treating vascular disease

Cycle Pharmaceuticals receives license for IP on PARP inhibitor drugs for treating vascular disease

Cambridge Enterprise has exclusively licensed intellectual property relating to the use of PARP inhibitor drugs for treating vascular disease to CYCLE Pharmaceuticals. [More]
Blocking protein that initiates immune response against viral infections may help combat HIV

Blocking protein that initiates immune response against viral infections may help combat HIV

In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV. [More]
Localized chemotherapy may be effective way to keep immune system intact, animal study suggests

Localized chemotherapy may be effective way to keep immune system intact, animal study suggests

In experiments on mice with a form of aggressive brain cancer, Johns Hopkins researchers have shown that localized chemotherapy delivered directly to the brain rather than given systemically may be the best way to keep the immune system intact and strong when immunotherapy is also part of the treatment. [More]
Rice bioengineers reveal how heart valves use different strategies to handle oxygen starvation

Rice bioengineers reveal how heart valves use different strategies to handle oxygen starvation

As the valves in a heart stretch with each beat, their cells take in life-giving oxygen. But if the supply is cut off, aortic and mitral valves use different strategies to compensate, according to Rice University scientists. [More]
Researchers find effective cure for social anxiety disorders

Researchers find effective cure for social anxiety disorders

Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders. [More]
Clinical study tests adult stem cell therapy for infants with congenital HLHS

Clinical study tests adult stem cell therapy for infants with congenital HLHS

In a first-in-children randomized clinical study, medical researchers at the University of Maryland School of Medicine and the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine have begun testing to see whether adult stem cells derived from bone marrow benefit children with the congenital heart defect hypoplastic left heart syndrome (HLHS). [More]
Breast cancer patient finds new hope with potentially revolutionary treatment

Breast cancer patient finds new hope with potentially revolutionary treatment

City of Hope patient Susan Young has had a remarkable response to a potentially revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding protein. [More]
Gelatin supplement consumption plus intensive exercise can help build ligaments, tendons and bones

Gelatin supplement consumption plus intensive exercise can help build ligaments, tendons and bones

A new study from Keith Baar's Functional Molecular Biology Laboratory at the UC Davis College of Biological Sciences and the Australian Institute of Sport suggests that consuming a gelatin supplement, plus a burst of intensive exercise, can help build ligaments, tendons and bones. [More]
Scientists develop 'LevelCheck' algorithm to help identify, label vertebrae during spine surgery

Scientists develop 'LevelCheck' algorithm to help identify, label vertebrae during spine surgery

Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a way to automatically label images of individual vertebrae during spine surgery, preventing mistakes and saving surgeons both time and stress in the operating room. [More]
Scientists develop better material to regenerate bone tissue cells in shorter time

Scientists develop better material to regenerate bone tissue cells in shorter time

A new study has revealed a technology how to cover biodegradable implants with a human skeleton similar mineral. [More]
A positive announcement for DePuy Synthes’ ATTUNE® Knee System

A positive announcement for DePuy Synthes’ ATTUNE® Knee System

DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes’ ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems. [More]
Researchers use CRISPR-based genetic screening to identify three promising HIV treatment targets

Researchers use CRISPR-based genetic screening to identify three promising HIV treatment targets

Investigators from Whitehead Institute, the Ragon Institute of MGH, MIT and Harvard and the Broad Institute of MIT and Harvard have used CRISPR-Cas9 gene-editing technology to identify three promising new targets for treatment of HIV infection. [More]
New review explores approaches for prevention of hip fracture in very high risk patients

New review explores approaches for prevention of hip fracture in very high risk patients

Hip fractures are of great concern as they are the most severe type of fracture in osteoporotic patients, associated with premature death, and commonly leading to long-term physical disability, impaired capacity to perform daily activities and live independently, and reduced quality of life. [More]
FDA awards accelerated approval to new ovarian cancer drug

FDA awards accelerated approval to new ovarian cancer drug

The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. [More]
How to stay safe in the sun

How to stay safe in the sun

When choosing a sunscreen, you must first consider what you will be doing when wearing it, for example if you're running, the sunscreen you choose must be able to withstand sweating. [More]
ESMO Asia 2016: Three studies present first data on rare sarcomas in Asian patients

ESMO Asia 2016: Three studies present first data on rare sarcomas in Asian patients

The first data on rare sarcomas in Asian patients is presented in three studies today at the ESMO Asia 2016 Congress in Singapore. [More]
Research finds link between p53 pathway and ribosome biogenesis, nucleotide metabolism in DBA

Research finds link between p53 pathway and ribosome biogenesis, nucleotide metabolism in DBA

Diamond Blackfan Anemia (DBA) is a condition that is characterized by a failure of the bone marrow to produce red blood cells, congenital abnormalities, and a predisposition to cancer. [More]
New clinical study for children with AML aims to kill leukemia cells and minimize cardiac damage

New clinical study for children with AML aims to kill leukemia cells and minimize cardiac damage

Imagine conquering childhood cancer, only to find out that years down the road your heart may fail. [More]
Study provides new insights into fundamental characteristics of dendritic cells

Study provides new insights into fundamental characteristics of dendritic cells

Dendritic cells represent an important component of the immune system: they recognize and engulf invaders, which subsequently triggers a pathogen-specific immune response. [More]
First-in-human study of cell bandage for common sporting knee injury shows promising results

First-in-human study of cell bandage for common sporting knee injury shows promising results

A 'living bandage' made from stem cells, which could revolutionise the treatment and prognosis of a common sporting knee injury, has been trialled in humans for the first time by scientists at the Universities of Liverpool and Bristol. [More]
Advertisement
Advertisement